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The adaptation of the agar colony-forming assay to
the study of proliferation and drug sensitivity
determination in solid tumours has presented many
problems. First has been the necessity to obtain an
adequate viable tumour sample. Next have been the
difficulties associated with dissociation of the
sample with production of a single cell suspension
that does not reaggregate and the establishment of
culture conditions that permit maximum cloning
efficiency (CE) for the range of tumours to be
studied. Finally comes the necessity for patience,
for it is important that such cultures are given
sufficient time to develop the maximum achievable
number of colonies.
Most studies using these systems have
concentrated on adult solid tumours (Salmon et al.,
1978; Courtenay et al., 1978; Pavelic et al., 1980);
few have addressed paediatric solid tumours. Those
which have were limited to single tumour types
such as Wilms' tumour (Dow et al., 1982) and
neuroblastoma (Von Hoff et al., 1980). Basic
differences in derivation, growth rate and size
between the majority of childhood and adult
neoplasms limit the extrapolation of results from
adult studies to those on paediatric tumours. In this
study we have assessed the application of the agar
colony-forming assay to an unselected series of
paediatric solid tumours.
Forty-seven consecutive biopsy specimens from
40 children aged up to 15 years were studied.
Patients with leukaemia or lymphoma were
excluded from this study. Results of studies on
acute myelocytic leukaemia have been reported
elsewhere (Lihou & Smith, 1983). All studies were
made on material collected at operations performed
for clinical reasons and remaining after sufficient
tissue had been taken for clinical laboratory study.
Tumour specimens trimmed of normal tissue
were weighed and then cut into pieces of less than
1 mm diameter in 50ml RPMI 1640 medium using
dental wax for support. The mince obtained by this
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procedure was centrifuged and resuspended in
RPMI 1640 medium containing 10% foetal calf
serum (FCS) and 0.1% collagenase (Sigma Type II)
to give 50ml medium g-1 tissue and then incubated
at 37°C without agitation. Dissociation was
assessed at 2h and if cell yield was inadequate,
continued overnight. After incubation the tissue
was triturated to aid dissociation. The cell rich
supernate was collected after the clumps had been
allowed to settle for 7min. Cells were washed free
of enzyme and counted in haemocytometers using
trypan blue dye exclusion to indicate viability.
Blood cells were excluded from the counts on the
basis of morphology.
Reaggregation was sometimes seen after
dissociation, this being more common in samples
with low viability where aggregates
characteristically formed "gelatinous strings". A
brief incubation at room temperature with 0.1%
deoxyribonucleotidase was employed to disperse
these aggregates.
Only 22 (47%) out of 47 samples weighed more
than 1 g. Sample size was most satisfactory with
primary Wilms' tumour where 10/11 specimens
exceeded 1 g in weight.
There was considerable variation in cell yield
when samples were compared both within groups
and between groups. The Wilms' tumour and
retinoblastoma samples consistently gave the
highest cell yields g-1. Each of the 13 Wilms'
tumour samples yielded > 107 viable cells g-1 with
6/13 yielding > 108 viable cells g-. The primary
Wilms' tumour specimens gave particularly high
total cell yields because of the combination of high
sample weight and high cell yield g-1 of tissue. The
lowest recovery from any specimen was 6.5 x 105
viable cells g 1 from a rhabdomyosarcoma
specimen.
Cells suspended in 0.28% nutrient agar medium
(Sheridan & Simmons, 1981) were dispensed as 1 ml
aliquots onto 1 ml 0.5% nutrient agar underlayers
in 35mm petri dishes. When yields permitted, a
range of cell concentrations from 5 x 103, to
106ml- was assessed. The majority of the plates
were then incubated at 37°C in an atmosphere of542 G.A. ABLETT et al.
5% C02, 5% 029 90% N2 and 100% humidity
(Courtenay, 1976).
Remaining replicate plates from each
concentration were fixed immediately after gelling
using 1 ml of 3% glutaraldehyde in cacodylate
buffer and stored in a refrigerator. These fixed
plates were compared with incubated plates on the
day of scoring as a check on aggregation which
may have occurred during or immediately after
plating. Great care was taken to screen for the
presence of clumps or small aggregates of cells,
such as doublets or triplets, especially in plates
containing a high cell concentration. This was
necessary because cells in such aggregates would
not be clonally derived and would need to undergo
fewer divisions to form aggregates that could be
mistakenly scored as colonies. A more serious error
would have been to overlook larger aggregates of
cells, present from the time of plating, which might
later be scored as colonies even in the absence of
division. As has been previously discussed (Selby et
al., 1983), the presence of one such aggregate per
thousand cells plated, if not noted, would give a
spurious plating efficiency of 0.1%. In these
experiments the presence of sufficient clumps to
account for more than a 5% contribution to the
colony count led to repetition of the experiment.
Colonies of 40 cells or more were scored using an
Olympus dissecting microscope at a magnification
of 25X. Results are expressed as cloning efficiency
(CE), that is, the number of colonies counted per
plate divided by the number of cells plated,
expressed as a percentage.
Colony scoring was performed on triplicate or
quadruplicate plates and for colony counts of 50-
200 per plate gave a standard deviation of < 10%.
Statistical analysis was done using non-parametric
or contingency table analysis as indicated in the
text.
It has been suggested that semi-solid cultures
should be scored for colony numbers at 2 weeks
(Salmon et al., 1978). However the slow growth
rate of most tumours would suggest that a longer
culture duration might be more satisfactory. To
assess the effect of culture duration on CE, 18
samples were scored at both 2 and 4 weeks. The
results showed that overall, the number of colonies
scored at 4 weeks (median 15; range 0-651) was
significantly higher than at 2 weeks (median 0;
range 0-104) (Wilcoxon Test for pair differences:
P<0.01) with 7 samples showing a marked increase
in CE at 4 weeks.
Thus scoring at 4 weeks was employed in all
other studies reported in this paper.
The tumour samples were classified into 4
groups: Wilms' tumours, sarcomas, neurogenic
tumours and miscellaneous tumours as shown in
Table I.
Of the 47 tumour specimens received 28 (60%)
formed colonies in agar medium (Table I). This
result was similar to that found by others with
paediatric tumours, 50%, (McAllister & Reed,
1968); and adult tumours, 62% (Hamburger et al.,
1981) and 55%, (Courtenay et al., 1978). Twenty-
three (58%) of the 40 patients had tumours which
contained cells that formed colonies in agar. Twelve
of the specimens had a CE >0.1%. Seven of the 13
sarcoma specimens formed colonies, Ewing's
tumours growing most successfully with 4 of the 5
specimens forming colonies with CE ranging up to
11.7%. From Table I it can be seen that 11/18
(61%) Wilms' tumour specimens formed colonies in
agar. CEs were generally low in the Wilms'
specimens with only 3 of the 18 samples having CE
greater than 0.1%. The CEs of the neurogenic
tumours were generally low also. Problems with cell
aggregation, especially when high cell
concentrations were used, were particularly marked
with this group of tumours and thus limited the cell
concentration assessable. Five of the 6
miscellaneous group of tumours formed colonies in
agar with 3 of them having a CE of >0.1%.
Sufficient numbers of samples from both primary
and secondary Wilms' tumours were studied to
enable a comparison of the CEs of these 2 groups
to be made. The CEs for the secondary Wilms'
tumours were significantly higher than for the
primary tumours. (Wilcoxon Rank Sum, P<0.01).
Four of 7 secondary tumour samples had CEs
greater than 0.1% compared with only 1/11
primary samples. This difference was also
significant (Fisher's Exact Test, P<0.05). This
observation suggests that there were more tumour
stem cells in the secondary lesions, that these cells
were less anchorage dependent, or that these cells
were less exacting in their growth requirements and
thus grew better in the nutrient agar.
The purpose of this investigation was to
determine the effectiveness of the anchorage
independent colony forming assay with regard to
paediatric tumours. This was done to assess its
potential in such clinical applications as predictive
drug sensitivity assays.
The problems encountered in this study included
limited specimen size, variable cell yields,
persistence of clumps, reaggregation especially at
high cell concentrations, low CEs, and slow growth
rates or delayed initiation of colonies. Each of these
problems was seen in at least one of the specimens
studied.
Of the 60% of specimens which formed colonies
many were not suitable for further study either
because the total cell yield was too low for
sufficient cells to be stored, the CE was too low, or
both. In general, the tumours studied here
dissociated readily to give a reasonable yield ofAGAR ASSAY AND PAEDIATRIC TUMOURS 543
Table I Maximum cloning efficiencies of paediatric tumours studied
Group I Group 2 Group 3 Group 4
Wilms' tumours Sarcomas Neurogenic tumours Miscellaneous tumours
Tumour % Cloning % Cloning % Cloning % Cloning
(Wilms') efficiency Tumour efficiency Tumour efficiency Tumour efficiency
loa 0.068 Ewings 10 11.7 Retinoblastoma 10 0 Hepatoblastoma 10 0.047
2oa 0 Ewings 10 0 Retinoblastoma 10 0 Hepatocarcinoma 10 0.012
2oa 0.164 Ewings 10 1.30 Retinoblastoma 1° 0 Teratoma 1° 0.28
2oa 0.07 Ewings 20 0.21 Neuroblastoma 10 0 Histiocytosis 1° 0
job 0.085 Ewings 1° 0.06 Neuroblastoma 1° 1.06 Histocytosis 1° 0.042
2ob 0.164 Osteosarcoma 10 0.42 Neuroblastoma 10 0 Histocytosis 1° 0.13
2ob 0.008 Rhabdomyosarcoma 10 0.10 Neuroblastoma 2° 0.017
2ob 1.41 Rhabdomyosarcoma 10 0 Neuroblastoma 1° 0
iobr 0 Rhabdomyosarcoma 10 0.007 Astrocytoma 10 0.64
20 0.048 Rhabdomyosarcoma 1° 0 Medulloblastoma 1 0.015
10 0 Neurofibrosarcoma 10 0
10 0 Leiomyosarcoma 10 0
10 0 Soft tissue sarcoma 1° 0
10 0.002
10 0.003
10 0
10 0
1° 0.056
a-Tumour from different sites in one patient
b Tumour from different sites in one patient
rPrimary recurrence.
viable cells. However since more than half the
samples received were small (<1 g) the total cell
yield was insufficient in many cases to provide the
2 x 107 cells needed for both initial study and
storage for further study once initial growth
characteristics had been determined. Since
reaggregation was a problem with tumour cell
concentrations of > 105cellsml-1 and a count of
50 colonies/plate is desirable in the untreated
control cultures, a CE of >0.05% is considered
necessary if the samples are to be useful for drug
sensitivity testing. Using these criteria and assuming
that fully validated methods for predictive drug
sensitivity testing were available, they would have
been applicable to only 9/47 (19%) samples in this
unselected series. On examining the sub-groups of
tumours, despite high cell yields only 2/18 (11%)
Wilms' tumours were suitable for further study
because of their low CEs whilst by contrast 6/13
(46%) sarcomas were suitable for further study.
These studies suggest that the application of this
methodology to the assessment of drug sensitivity
in paediatric neoplasms will remain premature until
significant methodological improvements are made.
Work needs to be done to improve culture
conditions by studying the individual growth
requirements of subclasses of tumours. Paediatric
sarcomas were found to be most amenable to study
using this system. With improved culture conditions
and careful attention to technique this methodology
may provide a useful approach to the study of
growth asid other properties of some classes of
paediatric tumours.
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